Anticancer Drugs in End‐Stage Kidney Disease Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-139x|28|4|413-416

ISSN： 0894-0959

Source： SEMINARS IN DIALYSIS, Vol.28, Iss.4, 2015-07, pp. : 413-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cochrane commentary

By  

NEPHROLOGY, Vol. 20, Iss. 4, 2015-04 ,pp. : 302-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clopidogrel Use in End‐Stage Kidney Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 3, 2015-05 ,pp. : 276-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 404-412

John Wiley & Sons Inc

Access to resources Recommend Favorite

SELF‐REPORTED MEDICATION ADHERENCE IN PATIENTS WITH END‐STAGE KIDNEY DISEASE UNDERGOING ONLINE‐HAEMODIAFILTRATION

By  

JOURNAL OF RENAL CARE, Vol. 41, Iss. 4, 2015-12 ,pp. : 231-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End‐Stage Renal Disease Due to Lupus Nephritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 4, 2015-04 ,pp. : 571-581

John Wiley & Sons Inc

Access to resources Recommend Favorite